200.51—Aqueous-based drug products for oral inhalation.
               		
               		
               	 	
               	 	
               	 	
               	 		
    
        
        (a) 
         All aqueous-based drug products for oral inhalation must be manufactured to be sterile.
     
    
        
        (b) 
         Manufacturers must also comply with the requirements in  § 211.113(b) of this chapter.
     
    
        
            Code of Federal Regulations
        
        [65 FR 34089, May 26, 2000]